J. Stern & Co. LLP, a registered investment adviser, initiated a new position in Thermo Fisher Scientific Inc. (NYSE:TMO) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 31,509,332 shares of the Healthcare company, valued at approximately $31.5B as of the filing date.
Thermo Fisher Scientific Inc.'s stock currently trades at $501.07 with a market capitalization of $219.4B.
